NALGONDA: The reactor explosion at Nosh Pharma Lab on the outskirts of Veliminedu village in Chityala mandal triggered ...
Indian pharmaceutical companies plan to invest $20.5 billion in the US, enhancing manufacturing and healthcare supply chains.
NALGONDA: One worker died and eight others sustained injuries on Friday after a reactor exploded at Nosh Pharma Lab on the ...
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved ...
Merck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific data. China's Zai Lab is looking to go ...
With the purchase of Organon & Co., billionaire Dilip Shanghvi's Sun Pharmaceutical Industries' annual revenue will more than ...
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
German specialty chemicals group Evonik (XETRA: EVK) has partnered with Japan’s Higuchi to launch a joint laboratory in ...
This explains how the regulatory framework strictly governs drug quality, manufacturing, and liability. Courts have clarified that liability cannot be imposed without clearly identifying the role of ...
Hindustan Laboratories Limited has received SEBI observations for its proposed IPO of up to 1,41,00,000 equity shares. The ...
Chityal (Nalgonda): A major industrial accident at Nosh Pharma Labs in Chityala Mandal claimed one life and left another ...
Sun Pharma's $11.75 billion buyout of Organon signifies a strategic shift from focusing on the US generics market to seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results